I-Mab | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (9)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
Article By: ChinaBio® Today
Sunday, February 11, 2024 12:40 PM EDT
I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 million.
In this article: BAYRY, TRIB, IMAB, IVBXF, ESAIY
Read
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
Article By: ChinaBio® Today
Saturday, October 14, 2023 12:59 PM EDT
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with potential value of more than $1 billion.
In this article: IMAB, KNTPF, ASPHF, SNY, BNTX Also: AZN, GSK
Read
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
Article By: ChinaBio® Today
Saturday, September 30, 2023 2:54 PM EDT
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals.
In this article: IMAB, ANL, ABBV, GRCL
Read
Week In Review: Sorrento Acquires ACEA In $488 Million Deal Between Two San Diego-China Oncology Biopharmas
Article By: ChinaBio® Today
Saturday, April 10, 2021 12:55 PM EDT
Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million. Both companies develop novel cancer drugs, both are headquartered in San Diego and both have operations in China. 
In this article: SRNE, HCM, BGNE, IMAB
Read
3 Outperforming IPO Stocks Flying Under The Radar
Article By: StockNews
Wednesday, December 23, 2020 7:23 AM EDT
Issuing stock in the public markets has been the rage this year. Whether through traditional initial public offerings (IPOs), direct listings, or special purpose acquisitions (SPAC deals), many companies made their stock market debuts in 2020.
In this article: BEAM, SDGR, IMAB
Read
All Posts

Latest Tweets for $IMAB

No tweets yet!

PARTNER HEADLINES